Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: In metastatic NET G1-G2 progressed after SSA, many treatment are appropriated including EV, CT and PRRT. However, there are no studies guiding the appropriate sequence of treatments.
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author: Marconcini R
Authors: Marconcini R, Ricci S, Antonuzzo A, Luca G, Vasile E,
Keywords: everolimus SSA,
Introduction: Oxaliplatine plus fluoropirimidine and capecitabine treatment alone are considered investigational treatments in well-differentiated (WD) NET
Conference: 12th Annual ENETSConcerence (2015)
Presenting Author: Marconcini R
Authors: Marconcini R, Ricci S, Galli L, Antonuzzo A, Vasile E,
Keywords: capecitabine, oxaliplatine ,
Introduction: NET is associated with a considerable HRQoL burden.
Conference: 11th Annual ENETSConcerence (2014)
Presenting Author:
Authors: Pavel M, Unger N, Borbath I, Ricci S, Hwang T,
Keywords: everolimus, QoL, NET,
Introduction: RAD001 has shown antitumor activity in pancreatic neuroendocrine tumors (NETs) and it seems to work synergistically with somatostatine analogues.
Conference:
Presenting Author:
Authors: Catena L, Biondani P, Fazio N, Giuffrida D, Ricci S,
Keywords: neuroendocrine tumors, everolimus, carcinoid,